Literature DB >> 15840688

Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2.

E Cario1.   

Abstract

Toll-like receptors (TLR) and NOD2 are emerging as key mediators of innate host defence in the intestinal mucosa, crucially involved in maintaining mucosal as well as commensal homeostasis. Recent observations suggest new (patho-) physiological mechanisms of how functional versus dysfunctional TLRx/NOD2 pathways may oppose or favour inflammatory bowel disease (IBD). In health, TLRx signalling protects the intestinal epithelial barrier and confers commensal tolerance whereas NOD2 signalling exerts antimicrobial activity and prevents pathogenic invasion. In disease, aberrant TLRx and/or NOD2 signalling may stimulate diverse inflammatory responses leading to acute and chronic intestinal inflammation with many different clinical phenotypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840688      PMCID: PMC1774880          DOI: 10.1136/gut.2004.062794

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  155 in total

1.  Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells.

Authors:  Puja Vora; Adrienne Youdim; Lisa S Thomas; Masayuki Fukata; Samuel Y Tesfay; Katie Lukasek; Kathrin S Michelsen; Akihiro Wada; Toshiya Hirayama; Moshe Arditi; Maria T Abreu
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

2.  Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island.

Authors:  Jérôme Viala; Catherine Chaput; Ivo G Boneca; Ana Cardona; Stephen E Girardin; Anthony P Moran; Rafika Athman; Sylvie Mémet; Michel R Huerre; Anthony J Coyle; Peter S DiStefano; Philippe J Sansonetti; Agnès Labigne; John Bertin; Dana J Philpott; Richard L Ferrero
Journal:  Nat Immunol       Date:  2004-10-17       Impact factor: 25.606

3.  Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition.

Authors:  Leonardo H Travassos; Stephen E Girardin; Dana J Philpott; Didier Blanot; Marie-Anne Nahori; Catherine Werts; Ivo G Boneca
Journal:  EMBO Rep       Date:  2004-09-10       Impact factor: 8.807

4.  ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance.

Authors:  Elizabeth K Brint; Damo Xu; Haiying Liu; Aisling Dunne; Andrew N J McKenzie; Luke A J O'Neill; Foo Y Liew
Journal:  Nat Immunol       Date:  2004-03-07       Impact factor: 25.606

5.  NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.

Authors:  J Wehkamp; J Harder; M Weichenthal; M Schwab; E Schäffeler; M Schlee; K R Herrlinger; A Stallmach; F Noack; P Fritz; J M Schröder; C L Bevins; K Fellermann; E F Stange
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

6.  A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter.

Authors:  Yan-Yi Wang; Lianyun Li; Ke-Jun Han; Zhonghe Zhai; Hong-Bing Shu
Journal:  FEBS Lett       Date:  2004-10-08       Impact factor: 4.124

7.  Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells.

Authors:  Jan-Michel Otte; Elke Cario; Daniel K Podolsky
Journal:  Gastroenterology       Date:  2004-04       Impact factor: 22.682

8.  In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain.

Authors:  Jean-Christophe Bambou; Antoine Giraud; Sandrine Menard; Bernadette Begue; Sabine Rakotobe; Martine Heyman; François Taddei; Nadine Cerf-Bensussan; Valérie Gaboriau-Routhiau
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

9.  Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin.

Authors:  Christian Maaser; Jan Heidemann; Christof von Eiff; Andreas Lugering; Thomas W Spahn; David G Binion; Wolfram Domschke; Norbert Lugering; Torsten Kucharzik
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

10.  Recognition of single-stranded RNA viruses by Toll-like receptor 7.

Authors:  Jennifer M Lund; Lena Alexopoulou; Ayuko Sato; Margaret Karow; Niels C Adams; Nicholas W Gale; Akiko Iwasaki; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

View more
  90 in total

Review 1.  Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa.

Authors:  Peter A Bron; Peter van Baarlen; Michiel Kleerebezem
Journal:  Nat Rev Microbiol       Date:  2011-11-21       Impact factor: 60.633

2.  Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation.

Authors:  C Kadota; S Ishihara; M M Aziz; M A Rumi; N Oshima; Y Mishima; I Moriyama; T Yuki; Y Amano; Y Kinoshita
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

3.  Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling.

Authors:  Shu-Chen Wei; Ian M Rosenberg; Zhifang Cao; Alan S Huett; Ramnik J Xavier; Daniel K Podolsky
Journal:  Inflamm Bowel Dis       Date:  2012-01-23       Impact factor: 5.325

Review 4.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

Review 5.  TLRs in the Gut I. The role of TLRs/Nods in intestinal development and homeostasis.

Authors:  Ian R Sanderson; W Allan Walker
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-07-13       Impact factor: 4.052

Review 6.  Immunopathogenesis of IBD: insufficient suppressor function in the gut?

Authors:  I L Huibregtse; A U van Lent; S J H van Deventer
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

Review 7.  Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense?

Authors:  Jan Heidemann; Wolfram Domschke; Torsten Kucharzik; Christian Maaser
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

8.  Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.

Authors:  A Grabig; D Paclik; C Guzy; A Dankof; D C Baumgart; J Erckenbrecht; B Raupach; U Sonnenborn; J Eckert; R R Schumann; B Wiedenmann; A U Dignass; A Sturm
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

9.  Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

Authors:  B Szebeni; G Veres; A Dezsõfi; K Rusai; A Vannay; M Mraz; E Majorova; A Arató
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

Review 10.  Microecology, intestinal epithelial barrier and necrotizing enterocolitis.

Authors:  Renu Sharma; Joseph J Tepas
Journal:  Pediatr Surg Int       Date:  2009-12-05       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.